clarithromycin has been researched along with Rhabdomyolysis in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (8.33) | 18.2507 |
2000's | 10 (41.67) | 29.6817 |
2010's | 10 (41.67) | 24.3611 |
2020's | 2 (8.33) | 2.80 |
Authors | Studies |
---|---|
Dejthevaporn, C; Kunakorntham, P; Pattanaprateep, O; Thakkinstian, A; Thammasudjarit, R | 1 |
Arnspang Pedersen, S; Bach Dunvald, AC; Bjerregaard Stage, T; Bruun Haastrup, M; Esbech, P; Hougaard Christensen, MM; Pilsgaard Henriksen, D; Thestrup Pedersen, AJ; Øhlenschlaeger, T | 1 |
Ben Zvi, I; Haj Yahia, S; Livneh, A | 1 |
Bykov, K; Gagne, JJ; Glynn, RJ; Mittleman, MA; Schneeweiss, S | 1 |
Bailey, DG; Fleet, J; Gandhi, S; Garg, AX; Gomes, T; Hwang, YJ; Juurlink, DN; Mamdani, M; Patel, AM; Shariff, S | 1 |
Coombes, I; Martin, JH | 1 |
Page, SR; Yee, KC | 1 |
Mustafa, G; Necati, B | 1 |
Bailey, DG; Dixon, S; Fleet, JL; Gandhi, S; Garg, AX; Gomes, T; Juurlink, D; Kim, R; Li, DQ; Mamdani, M; McArthur, E; Shariff, SZ | 1 |
Hill, FJ; McCloskey, SJ; Sheerin, N | 1 |
Cohen, O; Gorshtein, A; Hershko, AY; Levy, Y; Locketz, G | 1 |
Pfister, HW; Suessmair, C; Wagner, J | 1 |
Bergman, M; Bilik, I; Brener, ZZ; Khorets, B; Winchester, JF | 1 |
McKinnell, J; Tayek, JA | 1 |
Arnold, Ch; Hagmann, N; Lamy, O | 1 |
Bokhart, GH; Jones, RJ; Sipe, BE | 1 |
Gill, MJ; Mah Ming, JB | 1 |
Kahri, AJ; Pentikäinen, PJ; Valkonen, MM; Vuoristo, MK | 1 |
Arias, M; Rodrigo, E; Valero, R; Zubimendi, JA | 1 |
Emmett, L; Perera, C; Thanakrishnan, K; Trieu, J; Van Der Wall, H | 1 |
Andersson, KS; Molden, E | 1 |
Ebihara, I; Koide, H; Omuro, H; Saka, S; Shimada, N | 1 |
Freeman, NJ; Landesman, KA; Stozek, M | 1 |
Lee, AJ; Maddix, DS | 1 |
3 review(s) available for clarithromycin and Rhabdomyolysis
Article | Year |
---|---|
Interaction potential between clarithromycin and individual statins-A systematic review.
Topics: Area Under Curve; Clarithromycin; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rhabdomyolysis | 2020 |
Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B; Clarithromycin; Colchicine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Familial Mediterranean Fever; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunologic Factors; Male; Middle Aged; Polypharmacy; Rhabdomyolysis | 2015 |
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Rhabdomyolysis; Simvastatin; Sinusitis | 2001 |
21 other study(ies) available for clarithromycin and Rhabdomyolysis
Article | Year |
---|---|
Detection of statin-induced rhabdomyolysis and muscular related adverse events through data mining technique.
Topics: Bayes Theorem; Clarithromycin; Data Mining; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rhabdomyolysis | 2022 |
Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients.
Topics: Abdominal Pain; Adult; Aged; Clarithromycin; Colchicine; Drug Interactions; Familial Mediterranean Fever; Female; Helicobacter Infections; Humans; Middle Aged; Retrospective Studies; Rhabdomyolysis | 2018 |
The Case-Crossover Design for Drug-Drug Interactions: Considerations for Implementation.
Topics: Administrative Claims, Healthcare; Azithromycin; Clarithromycin; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Electronic Health Records; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Implementation Science; Models, Statistical; Rhabdomyolysis; Risk Factors; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome | 2019 |
Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Azithromycin; Cause of Death; Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Erythromycin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Retrospective Studies; Rhabdomyolysis | 2013 |
Mortality from common drug interactions systems, knowledge and clinical reasoning to optimise prescribing.
Topics: Clarithromycin; Female; Humans; Rhabdomyolysis; Simvastatin | 2014 |
Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin.
Topics: Aged, 80 and over; Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rhabdomyolysis; Simvastatin | 2014 |
Clarithromycin-associated rhabdomyolysis in an infant.
Topics: Anti-Bacterial Agents; Clarithromycin; Colchicine; Gout Suppressants; Humans; Male; Rhabdomyolysis | 2014 |
Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluorobenzenes; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperkalemia; Indoles; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Pravastatin; Pyrimidines; Retrospective Studies; Rhabdomyolysis; Rosuvastatin Calcium; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides | 2015 |
From a fish tank injury to hospital haemodialysis: the serious consequences of drug interactions.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Ethambutol; Finger Injuries; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mycobacterium Infections, Nontuberculous; Renal Dialysis; Rhabdomyolysis; Rifampin; Simvastatin | 2015 |
Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Contraindications; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Energy Metabolism; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iatrogenic Disease; Muscle Weakness; Muscle, Skeletal; Rhabdomyolysis; Risk Factors; Simvastatin | 2009 |
Rhabdomyolysis following clarithromycin monotherapy.
Topics: Anti-Bacterial Agents; Clarithromycin; Humans; Male; Middle Aged; Muscle Weakness; Rhabdomyolysis; Sinusitis | 2009 |
Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis.
Topics: Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Colchicine; Community-Acquired Infections; Doxycycline; Drug Interactions; Gout; Gout Suppressants; Humans; Male; Middle Aged; Pneumonia, Bacterial; Rhabdomyolysis; Treatment Outcome | 2009 |
[88 years old woman with acute muscular weakness and diffuse muscular pain: have you thought about the drugs?].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Anticholesteremic Agents; Clarithromycin; Diagnosis, Differential; Drug Interactions; Drug Therapy, Combination; Female; Humans; Muscle Weakness; Pain; Rhabdomyolysis; Simvastatin | 2010 |
Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction.
Topics: Atorvastatin; Clarithromycin; Drug Interactions; Esomeprazole; Female; Heart Block; Heptanoic Acids; Humans; Middle Aged; Pyrroles; Rhabdomyolysis | 2003 |
Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV.
Topics: Adult; Anti-Bacterial Agents; Atorvastatin; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lopinavir; Male; Pyrimidinones; Pyrroles; Rhabdomyolysis; Ritonavir | 2003 |
Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Male; Middle Aged; Rhabdomyolysis; Simvastatin | 2004 |
[Rhabdomyolysis secondary to the interaction of statins with macrolides in a renal transplant patient].
Topics: Aged; Anticholesteremic Agents; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Hyperlipidemias; Inactivation, Metabolic; Kidney Transplantation; Male; Postoperative Complications; Respiratory Tract Infections; Rhabdomyolysis; Simvastatin | 2004 |
Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Radionuclide Imaging; Radiopharmaceuticals; Respiratory Tract Infections; Rhabdomyolysis; Simvastatin; Technetium Tc 99m Medronate | 2004 |
Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Erythromycin; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Rhabdomyolysis; Simvastatin | 2007 |
[A case of acute renal failure with rhabdomyolysis caused by the interaction of theophylline and clarithromycin].
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bronchodilator Agents; Clarithromycin; Cytochrome P-450 Enzyme Inhibitors; Delayed-Action Preparations; Drug Interactions; Drug Therapy, Combination; Humans; Liver; Male; Rhabdomyolysis; Theophylline | 1999 |
Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
Topics: Adult; Aged; Anti-Bacterial Agents; Anticholesteremic Agents; Clarithromycin; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Rhabdomyolysis | 1999 |